Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Wijngaarde

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Orphanet Journal of Rare Diseases|April 13, 2017
Cardiac pathology in spinal muscular atrophy: a systematic reviewC A Wijngaarde, A C Blank, M Stam, et al.
European Journal of Neurology|December 2, 2017
Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4R I Wadman, C A Wijngaarde, M Stam, et al.
Journal of Neuromuscular Diseases|September 3, 2019
Bulbar Problems Self-Reported by Children and Adults with Spinal Muscular AtrophyA M B van der Heul, C A Wijngaarde, R I Wadman, et al.
Journal of Autoimmunity|April 23, 2019
The identification of CCL18 as biomarker of disease activity in localized sclerodermaJ S Mertens, E M G J de Jong, L L van den Hoogen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Orphanet Journal of Rare Diseases|April 13, 2017
Cardiac pathology in spinal muscular atrophy: a systematic reviewC A Wijngaarde, A C Blank, M Stam, et al.
European Journal of Neurology|December 2, 2017
Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4R I Wadman, C A Wijngaarde, M Stam, et al.
Journal of Neuromuscular Diseases|September 3, 2019
Bulbar Problems Self-Reported by Children and Adults with Spinal Muscular AtrophyA M B van der Heul, C A Wijngaarde, R I Wadman, et al.
Journal of Autoimmunity|April 23, 2019
The identification of CCL18 as biomarker of disease activity in localized sclerodermaJ S Mertens, E M G J de Jong, L L van den Hoogen, et al.
Pageof 1